Live Breaking News & Updates on Dennis turpin

Stay informed with the latest breaking news from Dennis turpin on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dennis turpin and stay connected to the pulse of your community

Albion City Council approves water plant contract

ALBION — Council members approved a water treatment plant agreement with W2E during a special meeting Tuesday night.

Milano , Lombardia , Italy , Grayville , Illinois , United-states , Albion , Don-rigg , Dennis-turpin , Marty-reid , Mount-carmel , Alderman-quentin-speir

Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders

Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Toronto , Ontario , Canada , Canadian , Peter-edwards , Carolyn-egbert , Dennis-turpin , Lou-gehrig , Jenene-thomas , Gilles-gagnon , Klaus-paulini , European-commission

Aeterna Zentaris : THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOUR OF ALL PROPOSED RESOLUTIONS - Form 6-K

THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOUR OF ALL PROPOSED RESOLUTIONS.


YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY.


May 9, 2023




... | May 23, 2023

Michigan , United-states , Brussels , Bruxelles-capitale , Belgium , Quebec , Canada , District-of-columbia , Seattle , Washington , Russia , Illinois

Lupin Pharma Canada announces the availability of Intrarosa® (prasterone vaginal ovules), a new treatment option in Canada for women with postmenopausal vulvovaginal atrophy

/CNW Telbec/ - Lupin Pharma Canada, a wholly-owned subsidiary of Lupin Limited (Lupin), announced today the launch of Intrarosa® (prasterone vaginal ovules)...

South-africa , Montreal , Quebec , Canada , Mumbai , Maharashtra , India , Canadian , Fernand-labrie , Asia-pacific , Dennis-turpin , Patrick-nadeau

Aeterna Zentaris Announces Results of 2021 Annual Meeting of Shareholders


Ernst & Young LLP was also appointed as the Company’s independent auditor at the AGM.
The Company is an “Eligible Interlisted Issuer” as such term is defined in the TSX Company Manual. As an Eligible Interlisted Issuer, the Company has relied on an exemption pursuant to Section 602.1 of the TSX Company Manual from Section 613 of the TSX Company Manual, the effect of which is that, subject to the satisfaction of certain conditions prescribed by the Toronto Stock Exchange, the Company will not have to comply with certain Canadian requirements in connection with the Company’s long-term incentive plan. As a result, shareholders were not asked to approve the unallocated entitlements under the Company’s long-term incentive plan at the AGM.

Canada , Toronto , Ontario , Canadian , Peter-edwards , Gilles-gagnon , Carolyn-egbert , Jenene-thomas , Dennis-turpin , Klaus-paulini , Linkedin , Aeterna-zentaris

Lupin, Endoceutics focus on women's health in Canada


Lupin, Endoceutics focus on women's health in Canada
Lupin, Endoceutics focus on women's health in Canada
09 March 2021 | News
Source credit: Shutterstock
Lupin Pharma, a subsidiary of global pharma major Lupin Ltd, has announced a partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialise Intrarosa® in Canada. 
Intrarosa® is Endoceutic’s flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone.
Commenting on the partnership, Dr Sofia Mumtaz, President, Lupin Pharma Canada said, “We are very pleased to partner with Endoceutics to bring this long-awaited innovative product to the Canadian market. Intrarosa will not only expand and strengthen our product portfolio into women’s health in Canada but will cater to satisfy the unmet medical needs.”

Canada , Canadian , Dennis-turpin , Lupin-ltd , Lupin-pharma , Lupin-pharma-canada , Chief-executive-officer , Lupin , Endoceutics , Intrarosa , Postmenopausal-vulvovaginal-atrophy , Vaginal-ovule